Sort
21,281 grants matching “influenza”
iPSC-derived macrophages as a model to study the genetic basis of inter-individual variation in immune responses to pathogens
$785,511Luis Bruno Barreiro · University Of Chicago · R01 · FY2025 · AI
Computational design and development of small protein inhibitors
$785,407Eva-Maria Strauch · Washington University · R01 · FY2024 · AI
Defining the role of T cell help in germinal centers by intercellular enzymatic labeling
$785,027Gabriel D Victora · Rockefeller University · R01 · FY2022 · AI
Core_RT-PCR based Case-Control: Apt Measure of Influenza Vaccine Effectiveness
$785,000Manjusha Gaglani · Scott And White Memorial Hospital · U01 · FY2012 · IP
Core_plus Option_A_C_Influenza Surveillance and Vaccine Effectiveness in a Large
$785,000Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2013 · IP
Core_RT-PCR based Case-Control: Apt Measure of Influenza Vaccine Effectiveness
$785,000Manjusha Gaglani · Scott And White Memorial Hospital · U01 · FY2013 · IP
Core_Prospective population-based estimation of influenza vaccine effectiveness a
$784,995Michael L Jackson · Kaiser Foundation Health Plan Of Washington · U01 · FY2013 · IP
Core_Prospective population-based estimation of influenza vaccine effectiveness a
$784,980Lisa A Jackson · Kaiser Foundation Health Plan Of Washington · U01 · FY2011 · IP
Core_Prospective population-based estimation of influenza vaccine effectiveness a
$784,950Lisa A Jackson · Kaiser Foundation Health Plan Of Washington · U01 · FY2012 · IP
Vaccines to Induce Functional Antibodies Targeting the V2 Loop
$784,933Susan B Zolla-Pazner · New York University School Of Medicine · P01 · FY2016 · AI
A Diagnostic Microarray for hemorrhagic fever encephalitis viruses
$784,825David Wang · Washington University · U01 · FY2010 · AI
Generation and Function of NK Cell Memory
$784,741Ulrich H Von Andrian · Harvard Medical School · R01 · FY2013 · AI
Eritoran (E5564), a TLR4 antagonist, as a novel therapeutic for influenza
$784,554Stefanie N. Vogel · University Of Maryland Baltimore · R01 · FY2013 · AI
Enhancing potency of the MERS vaccine by a novel ASP-1+alum adjuvant combination
$784,531Sara Lustigman · New York Blood Center · U01 · FY2017 · AI
Heterosubtypic immunity to influenza virus mediated by MHC-E-restricted memory NK cells
$784,398Stephanie Jost · Duke University · R01 · FY2022 · AI
Translational Geroscience Network
$784,286James L. Kirkland · Mayo Clinic Rochester · R33 · FY2023 · AG
Systems investigation of vaccine responses in aging and frailty
$784,057Albert C Shaw · Yale University · U19 · FY2024 · AI
Enhanced Detection System for Healthcare-Associated Transmission of Infection
$783,939Lee H. Harrison · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AI
A vaccine for genital herpes that achieves sterilizing immunity
$783,564Harvey Michael Friedman · University Of Pennsylvania · R01 · FY2021 · AI
Anti-Influenza Therapy in Hospitalized Patients with Community-Acquired Pneumonia
$783,522Julio Alberto Ramirez · University Of Louisville · U18 · FY2010 · IP
Effects of vitamin D and omega-3 fatty acids on infectious diseases and hCAP18
$783,256Carlos A. Camargo · Brigham And Women'S Hospital · R01 · FY2015 · AI
Monitoring System For Vector-Based Influenza Vaccine
$783,129Matthew M. Ferris · Indevr, Inc. · R44 · FY2008 · AI
Transcriptomic Signatures of Influenza Vaccine Responses
$782,918Gregory A. Poland · Mayo Clinic Rochester · R01 · FY2021 · AI
Structural interrogation of vaccine- and infection-induced B cell responses
$782,700Goran Bajic · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$782,691Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2023 · CA